Li ZHAO, Yong-Hong LIU, Kai-Rui LI, Bo HE, Fei LI, Lu-Yao ZHANG, Jiao-Jiao PAN, Qiang-Rong WANG

Çin’in Güney Xinjiang Bölgesinde Rhipicephalus (Boophilus) microplus’a Karşı Yüksek Verimli Aşı İçin Ön Çalışma

Sığır besiciliğinde Rhipicephalus (Boophilus) microplus’un doğrudan oluşturduğu hasar ve yayılımı oldukça ciddi bir problem olup, geleneksel kimyasal akarisitlerin kontrolde pek çok dezavantajları vardır ve aşı ile koruma ve kontrol alternatif olabilir. Rhipicephalus (Boophilus) microplus Bm86 temelli hazırlanan ve ticari olarak mevcut olan aşı bazı bölgelerde yetiştiriciler ve veteriner hekimler tarafından tercih edilmektedir, ancak genetik varyasyondan dolayı azalmış etkisi gibi negatif tarafları bulunmaktadır. Bm91 ve Bm86’nin birlikte bulunması Bm86’nın bağışıklık oluşturma etkisini artırabileceğinden aynı zamanda DNA aşıların özelliklerinden dolayı DNA aşısının protein aşı ile kombinasyonu bağışıklık etkisini artırabilir. Bu çalışmada yerel Rhipicephalus (Boophilus) microplus türü ile Bm86 ve Bm91 proteinlerinin prokaryotik ekspresyon sistemi ve CpG sekansı içeren pVAXI prokaryotik ekspresyon vektörü aracılı Bm86 ve Bm91 çift gen ökaryotik ekspresyon sistemi kullanıldı. Bu çalışma, Bm86 ve Bm91 proteinleri karışımı ile Bm86 ve Bm91 çift gen taşıyan aşı materyali oluşturmuş, böylece kene kontrolünde çoklu antijen protein ve çoklu gen taşıyan aşı ile koimmunizasyon için bir araç oluşturmuştur.

Preliminary Study of High Efficiency Vaccine of Rhipicephalus (Boophilus) microplus in South Xinjiang, China

The direct damage and spread of pathogens of Rhipicephalus (Boophilus) microplus to cattle -based livestock is extremely serious, the traditional chemical acaricides control have many disadvantages, and vaccine prevention and control is a potential alternative. The commercially available vaccine, based on Rhipicephalus (Boophilus) microplus Bm86, has been favored by farmers and veterinarians in some areas, but it also has drawbacks such as reduced effectiveness due to genetic variation. Based on the fact that Bm91 and Bm86 sharing can enhance the immune effect of Bm86, as well as the characteristics of DNA vaccines, the combination of DNA vaccine and protein vaccine enhanced the immune effect. In this study, adopts the local Rhipicephalus (Boophilus) microplus strains, using prokaryotic expression system preparation Bm86 and Bm91 proteins, and using the eukaryotic expression vector pVAXl containing the CpG sequences constructed Bm86 and Bm91 double gene eukaryotic expression system. This research provides materials for the next step of Co-immunizing animals with Bm86 and Bm91 mixed proteins with Bm86 and Bm91 dual-gene carriers, it also provides a way for co-immunization with multi-antigen protein and multi-gene carriers to control ticks.

PDF

___

1. Peter RJ, Van den Bossche P, Penzhorn BL, Sharp B: Tick, fly, and mosquito control-lessons from the past, solutions for the future. Vet Parasitol, 132, 205-215, 2005. DOI: 10.1016/j.vetpar.2005.07.004
2. De la Fuente J, Estrada-Peña A, Venzal JM, Kocan KM, Sonenshine DE: Overview: Ticks as vectors of pathogens that cause disease in humans and animals. Front Biosci, 13, 6938-6946, 2008. DOI:10.2741/3200
3. Dantas-Torres F, Chomel BB, Otranto D: Ticks and tick borne diseases: A one health perspective. Trends Parasitol, 28, 437-446, 2012. DOI: 10.1016/ j.pt.2012.07.003
4. Chen Z, Liu Q, Liu JQ, Xu BL, Lv S, Xia S, Zhou XN: Tick-borne pathogens and associated co-infections in ticks collected from domestic animals in central China. Parasit Vector, 7:237, 2014. DOI: 10.1186/17563305-7-237
5. Jabbar A, Abbas T, Sandhu ZD, Sandhu ZU, Saddiqi HA, Qamar MF, Gasser RB: Tick borne diseases of bovines in Pakistan: Major scope for future research and improved control. Parasit Vector, 8:283, 2015. DOI: 10.1186/s13071-015-0894-2
6. Yu Z, Wang H, Wang T, Sun W, Yang X, Liu J: Tick-borne pathogens and the vector potential of ticks in China. Parasit Vector, 8:24, 2015. DOI: 10.1186/s13071-014-0628-x
7. Csordas BG, Garcia MV, Cunha RC, Giachetto PF, Blecha IM, Andreotti R: New insights from molecular characterization of the tick Rhipicephalus (Boophilus) microplus in Brazil. Rev Bras Parasitol Vet, 25, 317-326, 2016. DOI: 10.1590/s1984-29612016053
8. Kamani J, Apanaskevich DA, Gutiérrez R, Nachum-Biala Y, Baneth G, Harrus S: Morphological and molecular identification of Rhipicephalus (Boophilus) microplus in Nigeria, West Africa: A threat to livestock health. Exp Appl Acarol, 73, 283-296, 2017. DOI: 10.1007/s10493-017-0177-z
9. Tonnesen MH, Penzhorn BL, Bryson NR, Stoltsz WH, Masibigiri T: Displacement of Boophilus decoloratus by Boophilus microplus in the Soutpansberg region, Limpopo province, South Africa. Exp Appl Acarol, 32, 199-208, 2004. DOI: 10.1023/b:appa.0000021789.4441.b5
10. Evans DE, Martins JR and Guglielmone AA: A review of the ticks (Acari, Ixodida) of Brazil, their hosts and geographic distribution-1. The state of Rio Grande do Sul, Southern Brazil. Mem Inst Oswalso Cruz Rio de Janeiro, 95, 453-470, 2000. DOI: 10.1590/s0074-02762000000400003
11. Estrada-Peña A, Bouattour A, Camicas JL, Guglielmone A, Horak I, Jongejan F, Latif A, Pegram R, Walker AR: The known distribution and ecological preferences of the tick subgenus Boophilus (Acari: Ixodidae) in Africa and Latin America. Exp Appl Acarol, 38, 219-235, 2006. DOI: 10.1007/ s10493-006-0003-5
12. Chen Z, Yang XJ, Bu FJ, Yang X, Yang X, Liu J: Ticks (Acari: Ixodoidea: Argasidae, Ixodidae) of China. Exp Appl Acarol, 51, 393-404, 2010. DOI: 10.1007/s10493-010-9335-2
13. Nolan J, Wilson JT, Green PE, Bird PE: Synthetic pyrethroid resistance in field samples in the cattle tick (Boophilus microplus). Aus Vet J, 66, 179182, 1989. DOI: 10.1111/j.1751-0813.1989.tb09796.x
14. Willadsen P: Novel vaccines for ectoparasites. Vet Parasitol, 71, 209222, 1997. DOI:10.1016/s0304-4017(97)00028-9
15. Anbarasi P, Latha BR, Dhinakar RG, Sreekumar C, Senthuran S: Partial sequencing of Bm86 gene for studying the phylogeny of an Indian isolate of Rhipicephalus (Boophilus) microplus tick. J Parasit Dis, 38, 260264, 2014. DOI: 10.1007/s12639-012-0228-7
16. Ramírez Rodríguez PB, Rosario Cruz R, Domínguez García DI, Hernández Gutiérrez R, Lagunes Quintanilla RE, Ortuño Sahagún D, González Castillo C, Gutiérrez Ortega A, Herrera Rodríguez SE, Vallejo Cardona A, Martínez Velázquez M: Identification of immunogenic proteins from ovarian tissue and recognized in larval extracts of Rhipicephalus (Boophilus) microplus, through an immunoproteomic approach. Exp Parasitol, 170, 227-235, 2016. DOI: 10.1016/j. exppara.2016.10.005
17. Hüe T, Petermann J, Bonnefond R, Mermoud I, Rantoen D, Vuocolo T: Experimental efficacy of a vaccine against Rhipicephalus australis. Exp Appl Acarol, 73, 245-256, 2017. DOI: 10.1007/s10493-017-0184-0
18. De la Fuente J, Rodrı´guez M, Montero C, Redondo M, GarcíaGarcía JC, Méndez L, Serrano E, Valdés M, Enríquez A, Canales M, Ramos E, Boué O, Machado H, Lleonart R: Vaccination against ticks (Boophilus spp.): The experience with the Bm86-based vaccine GavacTM. Genet Anal Biomol E, 15, 143-148, 1999. DOI: 10.1016/S1050-3862(99)00018-2
19. De la Fuente J, Almazán C, Canales M, Pérez de la Lastra JM, Kocan KM, Willadsen P: A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim Health Res Rev, 8, 23-28, 2007. DOI: 10.1017/s1466252307001193
20. Valle MR, Mèndez L, Valdez M, Redondo M, Espinosa CM, Vargas M, Cruz RL, Barrios HP, Seoane G, Ramirez ES, Boue O, Vigil JL, Machado H, Nordelo CB, Piñeiro MJ: Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Exp Appl Acarol, 34, 375-382, 2004. DOI: 10.1023/b:appa.0000049223.92326.02
21. Suarez M, Rubi J, Pérez D, Cordova V, Salazar Y, Vielma A, Barrios F, Gil CA, Segura N, Carrillo Y, Cartaya R, Palacios M, Rubio E, Escalona C, Ramirez RC, Baker RB, Machado H, Sordo Y, Bermudes J, Vargas M, Montero C, Cruz A, Puente P, Rodriguez JL, Mantilla E, Oliva O, Smith E, Castillo A, Ramos B, Ramirez Y, Abad Z, Morales A, Gonzalez EM, Hernandez A, Ceballo Y, Callard D, Cardoso A, Navarro M, Gonzalez JL, Pina R, Cueto M, Borroto C, Pimentel E, Carpio Y, Estrada MP: High impact and effectiveness of GavacTM vaccine in the national program for control of bovine ticks Rhipicephalus microplus in Venezuela. Livest Sci, 187, 48-52, 2016. DOI: 10.1016/j.livsci.2016.02.005
22. Rand KN, Moore T, Sriskantha A, Spring K, Tellam R, Willadsen P, Cobon GS: Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc Natl Acad Sci USA, 86, 9657-9661, 1989. DOI: 10.1073/pnas.86.24.9657
23. Willadsen P, Riding GA, McKenna RV, Kemp DH, Tellam RL, Nielsen JN, Lahnstein J, Cobon GS, Gough JM: Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus. J Immunol, 143, 1346-1351, 1989.
24. Gough JM, Kemp DH: Localization of a low abundance membrane protein (Bm86) on the gut cells of the cattle tick Boophilus microplus by immunogold labeling. J Parasitol, 79, 900-907, 1993. DOI: 10.2307/3283728
25. Willadsen P, Kemp DH: Vaccination with ’concealed’ antigens for tick control. Parasitol Today, 4, 196-198, 1988.
26. De la Fuente J, Rodriguez M, Redondo M, Montero C, García-García JC, Méndez L, Serrano E, Valdés M, Enriquez A, Canales M, Ramos E, Boué O, Machado H, Lleonart R, de Armas CA, Rey S, Rodríguez JL, Artiles M, García L: Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus. Vaccine, 16, 366-373, 1998. DOI: 10.1016/S0264-410X(97)00208-9
27. Garcia-Garcia JC, Montero C, Redondo M, Vargas M, Canales M, Boue O, Rodríguez M, Joglar M, Machado H, González IL, Valdés M, Méndez L, de la Fuente J: Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine, 18, 2275-2287, 2000. DOI: 10.1016/S0264-410X(99)00548-4
28. Ruiz LM, Orduz S, López ED, Guzmán F, Patarroyo ME, Armengol G: Immune response in mice and cattle after immunization with a Boophilus microplus DNA vaccinecontaining bm86 gene. Vet Parasitol, 144, 138-145, 2007. DOI: 10.1016/j.vetpar.2006.09.033
29. Cunha RC, Pérez de León AA, Leite FP, Pinto Lda S, Dos Santos Júnior AG, Andreotti R: Bovine immunoprotection against Rhipicephalus (Boophilus) microplus with recombinant Bm86-campo grande antigen. Rev Bras Parasitol Vet, 21, 254-262, 2012. DOI: 10.1590/S1984-29612012000300014
30. Ali A, Parizi LF, Guizzo MG, Tirloni L, Seixas A, Vaz Ida S Jr, Termignoni C: Immunoprotective potential of a Rhipicephalus (Boophilus) microplus metalloprotease. Vet Parasitol, 207, 107-114, 2015. DOI: 10.1016/ j.vetpar.2014.11.007
31. Willadsen P: Anti-tick vaccines. Parasitology, 129, S367-S387, 2004. DOI: 10.1017/S0031182003004657
32. Riding GA, Jarmey J, McKenna RV, Pearson R, Cobon GS, Willadsen P: A protective ‘concealed’ antigen from Boophilus microplus: Purification, localisation and possible function. J Immunol, 153, 5158-5166, 1994.
33. Willadsen P, Smith D, Cobon G, McKenna RV: Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86alone or in combination with recombinant Bm91. Parasite Immunol, 18, 241246, 1996. DOI: 10.1046/j.1365-3024.1996.d01-90.x
34. Nijhof AM, Taoufik A, de la Fuente J, Kocan KM, de Vries E, Jongejan F: Gene silencing of the tick protective antigens, Bm86, Bm91 and subolesin, in the one-host tick Boophilus microplus by RNA interference. Int J Parasitol, 37, 653-662, 2007. DOI: 10.1016/j.ijpara.2006.11.005
35. Lambertz C, Chongkasikit N, Jittapalapong S, Gauly M: Immune response of Bos indicus cattle against the anti-tick antigen Bm91 derived from local Rhipicephalus (Boophilus) microplus ticks and its effect on tick reproduction under natural infestation. J Parasitol Res, 2012:907607, 2012. DOI: 10.1155/2012/907607
36. Tighe H, Corr M, Roman M, Raz E: Gene vaccination: Plasmid DNA is more than just a blueprint. Immunol Today, 19, 89-97, 1998. DOI: 10.1016/ S0167-5699(97)01201-2
37. Babiuk LA, Hurk SDL, Babiuk SL: Immunization of animals: From DNA to the dinner plate. Vet Immunol Immunopathol, 72, 189-202, 1999. DOI: 10.1016/S0165-2427(99)00132-4
38. Imoto J, Konishi E: Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: A strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model. Viral Immunol, 18, 205-212, 2005. DOI: 10.1089/vim.2005.18.205
39. Ishikawa T, Takasaki T, Kurane I, Nukuzuma S, Kondo T, Konishi E: Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice. Microbes Infect, 9, 1089-1095, 2007. DOI: 10.1016/j.micinf.2007.05.013
40. Parizi LF, Githaka NW, Logullo C, Konnai S, Masuda A, Ohashi K, da Silva Vaz I Jr: The quest for a universal vaccine against ticks: Cross- immunity insights. Vet J, 194, 158-165, 2012. DOI: 10.1016/j.tvjl. 2012.05.023
41. Mastropaolo M, Mangold AJ, Guglielmone AA, Nava S: Nonparasitic life cycle of the cattle tick Rhipicephalus (Boophilus) microplus in Panicummaximum pastures in northern Argentina. Res Vet Sci, 115, 138145, 2017. DOI: 10.1016/j.rvsc.2017.03.009
42. Jongejan F, Uilenberg G: The global importance of ticks. Parasitol, 129, 1-12, 2004. DOI: 10.1017/S0031182004005967
43. Lew-Tabor AE, Bruyeres AG, Zhang B, Rodriguez Valle M: Rhipicephalus (Boophilus) microplus tick in vitro feeding methods for functional (dsRNA) and vaccine candidate (antibody) screening. Ticks Tick Borne Dis, 5, 500-510, 2014. DOI: 10.1016/j.ttbdis.2014.03.005
44. Jarmey JM, Riding GA, Pearson RD, McKenna RV, Willadsen P: Carboxydipeptidase from Boophilus microplus: A “concealed” antigen with similarity to angiotensin-converting enzyme. Insect Biochem Mol Biol, 25, 969-974, 1995. DOI: 10.1016/0965-1748(95)00038-W
45. Ruiz LM, Armengol G, Habeych E, Orduz S: A theoretical analysis of codon adaptation index of the Boophilus microplus bm86 gene directed to the optimization of a DNA vaccine. J Theor Biol, 239, 445-449, 2006. DOI: 10.1016/j.jtbi.2005.08.009
46. Kemp DH, Pearson RD, Gough JM, Willadsen P: Vaccination against Boophilus microplus: Localization of antigens on tick gut cells and their interaction with the host immune system. Exp Appl Acarol, 7, 43-58, 1989. DOI: 10.1007/BF01200452
47. Rose RD, Mckenna RV, Cobon G, Tennent J, Zakrzewski H, Gale K, Wood PR, Scheerlinck JP, Willadsen P: Bm86 antigen induces a protective immune response against Boophilus microplus, following dna and protein vaccination in sheep. Vet Immunol Immunopathol, 71, 151160, 1999. DOI: 10.1016/S0165-2427(99)00038-0
48. Glynn A, Freytag LC, Clements JD: Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine, 23, 1957-1965, 2005. DOI: 10.1016/j.vaccine.2004.10.025
49. Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LCS: Primeboost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, 23, 2430-2438, 2005. DOI: 10.1016/j.vaccine.2004.11.026
50. Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA: Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res, 105, 1767-1777, 2009. DOI: 10.1007/ s00436-009-1646-z
51. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol, 20, 709-760, 2002. DOI: 10.1146/annurev.immunol. 20.100301.064842